Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Stage

Biz Plan Competition | Alive

Total Raised

$80K

Last Raised

$80K | 3 yrs ago

About Velox Therapeutics

Velox Therapeutics developed an anticoagulant that does not increase the bleeding risk, thus lowering some safety issues related to current drugs.

Velox Therapeutics Headquarter Location

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.